comparemela.com
Home
Live Updates
EGFR-Targeted TKIs Continue to Have Outsized Impact in NSCLC : comparemela.com
EGFR-Targeted TKIs Continue to Have Outsized Impact in NSCLC
Thomas J. Lynch Jr, MD, details how treatments are evolving for patients with EGFR-mutated advanced non–small cell lung cancer.
Related Keywords
Washington ,
United States ,
Seattle ,
Hollywood ,
California ,
Lynch Jr ,
Thomasj Lynch Jr ,
Fred Hutch Cancer Center ,
Winter Lung Cancer ,
Raisbeck Endowed Chair ,
Lung Cancer ,
Amivantamab Treating Exon ,
Examining Osimertinib ,
Cancer Care Lecture ,
Winter Lung Cancer Conference ,
D ,
Patients With Egfr Mutated Advanced Non Small Cell Lung Cancer ,
comparemela.com © 2020. All Rights Reserved.